Immunexpress Begins US Commercialization of Near-Patient Sepsis Diagnostic Test
The company's test uses qPCR to measure the expression of two genes to determine the probability of sepsis.
Source: genomeweb.com
Stay updated with breaking news from Australia Based Immunexpress. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company's test uses qPCR to measure the expression of two genes to determine the probability of sepsis.